Odyssey Health, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
Odyssey Health, a medical product developer, faces significant going concern doubts and funding challenges despite progress in product development and a new sub-licensing agreement.
OQB
10-K: Odyssey Health Inc. Reports Full Year 2024 Results, Highlights Asset Sale and Ongoing Development
Odyssey Health Inc. reports its full year 2024 results, including a significant gain from the sale of assets to Oragenics, while continuing to develop its medical device technologies.